Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Neoplasms by Site 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Recurrence 1Neoplasms 1Neoplasm Metastasis 1Lung Diseases 1Lethal Congenital Contracture Syndrome 2 1Head and Neck Neoplasms 1Fibromatosis, Gingival, 2 1Carcinoma, Squamous Cell 1Carcinoma 1Bronchial Neoplasms 1Breast Neoplasms 1

Interventions

Pemetrexed 10Carboplatin 8pembrolizumab 7Cisplatin 7130-nm albumin-bound paclitaxel 6Paclitaxel 5Nivolumab 5Gemcitabine 5ribociclib 4palbociclib 4napabucasin 4durvalumab 4Fulvestrant 4Bevacizumab 4osimertinib 3abemaciclib 3Mitomycin 3Irinotecan 3Fluorouracil 3Drug Therapy 3Anastrozole 3Albumin-Bound Paclitaxel 3AZD9833 3selpercatinib 2pralsetinib 2patritumab 2ficlatuzumab 2exemestane 2atezolizumab 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms by Site × patritumab × Clear all
NCT02633800 2019-01-07

Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )

Daiichi Sankyo

Phase 2 Terminated
87 enrolled 13 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms by Site

NCT02134015 2018-01-23

HER3-Lung

Daiichi Sankyo

Phase 3 Terminated
145 enrolled 20 charts
Thoracic

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡